Impel Pharmaceuticals (FRA:84P) FCF Yield % : -22,834.54 (As of Jun. 03, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Impel Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Impel Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-76.59 Mil, and Market Cap is €0.87 Mil. Therefore, Impel Pharmaceuticals's FCF Yield % for today is -22,834.54%.

The historical rank and industry rank for Impel Pharmaceuticals's FCF Yield % or its related term are showing as below:

FRA:84P' s FCF Yield % Range Over the Past 10 Years
Min: -47941.2 Med: -127.05 Max: -23.11
Current: -22834.54

During the past 4 years, the highest FCF Yield % of Impel Pharmaceuticals was -23.11%. The lowest was -47941.20%. And the median was -127.05%.

FRA:84P's FCF Yield % is ranked worse than
99.61% of 1552 companies
in the Biotechnology industry
Industry Median: -14.1 vs FRA:84P: -22834.54

Impel Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2023 was -347.99%.

Impel Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Impel Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impel Pharmaceuticals FCF Yield % Chart

Impel Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Yield %

-34.53

-111.13

Impel Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial											-68.16	-88.88	-357.03	-292.32	-635.68

Competitive Comparison of Impel Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Impel Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impel Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impel Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Impel Pharmaceuticals's FCF Yield % falls into.

Impel Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Impel Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-89.698	/	80.71362
	=	-111.13%

Impel Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-16.38	*	4	/	10.307066
	=	-635.68%

Impel Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Impel Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Impel Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Impel Pharmaceuticals (FRA:84P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impel Pharmaceuticals Inc (FRA:84P) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

IMPLQ:USA

Address

201 Elliott Avenue West, Suite 260, Seattle, WA, USA, 98119

Website

https://www.impelpharma.com

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.

Impel Pharmaceuticals (FRA:84P) Headlines

No Headlines